Literature DB >> 32088934

Application of a social media platform as a patient reminder in the treatment of Helicobacter pylori.

Miaomiao Luo1, Yu Hao2, Ming Tang1, Mengzhen Shi1, Fengjuan He1, Yuanmao Xie1, Weigang Chen1.   

Abstract

BACKGROUND: To investigate the effect of a social media platform for the treatment of Helicobacter pylori infection.
MATERIALS AND METHODS: We enrolled 222 patients from October 2018 to June 2019, who required H pylori therapy. We used WeChat, a social media platform, as a patient reminder tool. They were randomly divided into the intervention and control groups (n = 111 per group) to compare and evaluate their disease awareness, medication adherence, incidence of adverse drug reactions, and H pylori eradication rate.
RESULTS: Patients in the intervention group had significantly better disease-related knowledge, medication adherence, and H pylori eradication rates than those in the control group (P < .05).
CONCLUSIONS: Using a social media platform may improve treatment rates of H pylori infection.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Helicobacter pylorizzm321990; medication adherence; social media platform

Year:  2020        PMID: 32088934     DOI: 10.1111/hel.12682

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  6 in total

1.  High-Dose Dual Therapy Versus Bismuth-Containing Quadruple Therapy for the Treatment of Helicobacter pylori Infection: A Systematic Review with Meta-Analysis.

Authors:  Zhikun Yin; Ji Li; Weifeng Huang; Xiaoyi Lei; Dong Xu; Guihua Xu; Hua Li; Jinyan Zhang
Journal:  Turk J Gastroenterol       Date:  2022-06       Impact factor: 1.555

2.  Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition).

Authors:  Song-Ze Ding; Yi-Qi Du; Hong Lu; Wei-Hong Wang; Hong Cheng; Shi-Yao Chen; Min-Hu Chen; Wei-Chang Chen; Ye Chen; Jing-Yuan Fang; Heng-Jun Gao; Ming-Zhou Guo; Ying Han; Xiao-Hua Hou; Fu-Lian Hu; Bo Jiang; Hai-Xing Jiang; Chun-Hui Lan; Jing-Nan Li; Yan Li; Yan-Qing Li; Jie Liu; You-Ming Li; Bin Lyu; You-Yong Lu; Ying-Lei Miao; Yong-Zhan Nie; Jia-Ming Qian; Jian-Qiu Sheng; Cheng-Wei Tang; Fen Wang; Hua-Hong Wang; Jiang-Bin Wang; Jing-Tong Wang; Jun-Ping Wang; Xue-Hong Wang; Kai-Chun Wu; Xing-Zhou Xia; Wei-Fen Xie; Yong Xie; Jian-Ming Xu; Chang-Qing Yang; Gui-Bin Yang; Yuan Yuan; Zhi-Rong Zeng; Bing-Yong Zhang; Gui-Ying Zhang; Guo-Xin Zhang; Jian-Zhong Zhang; Zhen-Yu Zhang; Peng-Yuan Zheng; Yin Zhu; Xiu-Li Zuo; Li-Ya Zhou; Nong-Hua Lyu; Yun-Sheng Yang; Zhao-Shen Li
Journal:  Gut       Date:  2021-11-26       Impact factor: 23.059

3.  Effects of WeChat platform-based health management on health and self-management effectiveness of patients with severe chronic heart failure.

Authors:  Zhan-Ru Wang; Jia-Wu Zhou; Xiao-Ping Liu; Guo-Juan Cai; Qi-Hong Zhang; Jun-Fang Mao
Journal:  World J Clin Cases       Date:  2021-12-06       Impact factor: 1.337

Review 4.  Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.

Authors:  Yaobin Ouyang; Wenjing Zhang; Chen He; Yin Zhu; Nonghua Lu; Yi Hu
Journal:  Front Med (Lausanne)       Date:  2022-03-24

Review 5.  Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection.

Authors:  Malek Shatila; Anusha Shirwaikar Thomas
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

Review 6.  AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infection: Expert Review.

Authors:  Shailja C Shah; Prasad G Iyer; Steven F Moss
Journal:  Gastroenterology       Date:  2021-01-29       Impact factor: 22.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.